Empowering the SPG11 Rare-Disease Community
A transparent portal providing caregivers and families with clear, objective educational blueprints to understand Spastic Paraplegia type 11 progression stages.
Our Genesis
Navigating a rare disease diagnosis is an intensely challenging experience. Families affected by Spastic Paraplegia type 11 (SPG11) are often presented with complex, clinical-heavy papers or disjointed support forum entries. The lack of structured, accessible materials created a massive informational gap for non-clinical caregivers.
The SPG11 Journey Tracker was founded by family advocates and disease researchers as a completely free, open-access static resource directory. Our mission is singular: to de-silo complex academic neurological literature, converting genetic, behavioral, and motoric milestones into structured learning parameters that empower parents and caregivers to plan ahead.
Our Editorial & Funding Standards
To guarantee complete neutrality, our editorial desk strictly refrains from reviewing or endorsing proprietary pharmaceuticals, clinical products, or commercial therapies. We present peer-reviewed diagnostic criteria and universally recognized support strategies objectively.
To keep this portal entirely open and accessible to all families worldwide, we serve highly vetted, contextual advertisements through Google AdSense. Ad configurations are heavily audited to ensure zero interference with the educational materials.
✅ Our Educational Guarantees
- ✓ 100% free educational resources compiled strictly from peer-reviewed clinical summaries.
- ✓ No proprietary diagnostic mechanisms or commercial medicine sales.
- ✓ Clear, upfront safety disclaimers separating advocacy from professional medical practice.
No Medical Advice
This portal is explicitly not a medical device, diagnosis tool, or therapeutic platform. It does not carry database systems or stateful tracking features.
Consult with specialized neuro-geneticists or certified clinical centers before executing physical therapies or dietary plans.
Rare Prevalence
SPG11 constitutes approximately 15-20% of autosomal recessive Hereditary Spastic Paraplegias, necessitating specialized educational hubs.